These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17328890

  • 21. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
    Park JY, Bae MA, Cheon HG, Kim SS, Hong JM, Kim TH, Choi JY, Kim SH, Lim J, Choi CH, Shin HI, Kim SY, Park EK.
    Biochem Biophys Res Commun; 2009 Jan 16; 378(3):645-9. PubMed ID: 19059209
    [Abstract] [Full Text] [Related]

  • 22. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ, Kim TH, Kwak HB, Lee ZH, Lee SY, Jhon GJ.
    J Ethnopharmacol; 2007 Sep 05; 113(2):191-8. PubMed ID: 17646068
    [Abstract] [Full Text] [Related]

  • 23. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH.
    Food Chem Toxicol; 2008 Nov 05; 46(11):3375-82. PubMed ID: 18786594
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9176-83. PubMed ID: 18823786
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.
    Bone; 2007 Oct 15; 41(4):592-602. PubMed ID: 17627913
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action.
    Idris AI, Ralston SH, van't Hof RJ.
    Eur J Pharmacol; 2009 Jan 14; 602(2-3):215-22. PubMed ID: 19046964
    [Abstract] [Full Text] [Related]

  • 32. Identification, structural determination, and biological activity of bovine and canine calcitonin receptor-stimulating peptides.
    Katafuchi T, Hamano K, Minamino N.
    Biochem Biophys Res Commun; 2004 Jan 02; 313(1):74-9. PubMed ID: 14672700
    [Abstract] [Full Text] [Related]

  • 33. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2.
    Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S, Kohashi O.
    J Immunol; 1999 Mar 01; 162(5):2754-60. PubMed ID: 10072521
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 01; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH.
    J Musculoskelet Neuronal Interact; 2006 Nov 01; 6(1):87-95. PubMed ID: 16675892
    [Abstract] [Full Text] [Related]

  • 38. Calcitonin receptor-stimulating peptide-1 regulates ion transport and growth of renal epithelial cell line LLC-PK1.
    Hamano K, Katafuchi T, Kikumoto K, Minamino N.
    Biochem Biophys Res Commun; 2005 Apr 29; 330(1):75-80. PubMed ID: 15781234
    [Abstract] [Full Text] [Related]

  • 39. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M, Ejiri S, Ozawa H.
    Bone; 2004 Jul 29; 35(1):27-33. PubMed ID: 15207738
    [Abstract] [Full Text] [Related]

  • 40. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption.
    Chang EJ, Ha J, Oerlemans F, Lee YJ, Lee SW, Ryu J, Kim HJ, Lee Y, Kim HM, Choi JY, Kim JY, Shin CS, Pak YK, Tanaka S, Wieringa B, Lee ZH, Kim HH.
    Nat Med; 2008 Sep 29; 14(9):966-72. PubMed ID: 18724377
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.